Risk of Upgrading at Final Pathology after Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsies: A Post Hoc Analysis of the PERFECT Trial.

IF 8.3 1区医学 Q1 ONCOLOGY

European urology oncology Pub Date : 2025-04-21 DOI:10.1016/j.euo.2025.03.018

Alessandro Uleri, Eric Barret, Gaëlle Fiard, Louis Lenfant, Bernard Malavaud, Raphaële Renard-Penna, François Rozet, Jean-Baptiste Beauval, Ambroise Salin, Morgan Rouprêt, Guillaume Ploussard

引用次数: 0

查看原文本刊更多论文

经会阴与经直肠磁共振成像靶向前列腺活检后最终病理升级的风险：PERFECT试验的事后分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format